Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,511.20 +123.61 0.80%
S&P 500 1,679.06 +9.90 0.59%
Nasdaq 3,522.68 +20.56 0.59%
Ticker Volume Price Price Delta
STOXX 50 2,833.22 +11.57 0.41%
FTSE 100 6,832.34 +28.47 0.42%
DAX 8,528.94 +56.74 0.67%
Ticker Volume Price Price Delta
Nikkei 15,627.30 +246.24 1.60%
Hang Seng 23,261.10 -105.29 -0.45%
S&P/ASX 200 5,165.37 -14.69 -0.28%
  • Exchange: EN Paris
  • Sector: Consumer, Non-cyclical
  • Industry: Healthcare-Products
  • Sub-Industry: Medical Products

Carmat

+ Add to Watchlist

ALCAR:FP

127.0100 EUR 1.1900 0.93%

As of 11:35:00 ET on 05/22/2013.

Company Profile for Carmat (ALCAR)

Carmat is medical technology start-up company. The Company intends to market a fully implantable artificial heart for patients suffering in the aftermath of a heart attack or with late-stage heart failure and for whom standard drug therapy, ventricular assistance and/or a heart transplant have failed or are not possible.

Contact Information

Carmat

36 avenue de l'Europe
CS 40533 - Immeuble l₣ 1/64 13/32Etenda
Velizy Villacoublay Cedex, 78941
France
Phone: 33-01-39456450
Fax: 33-01-39456451

Key Executives for Carmat (ALCAR)

Jean-Claude CadudalChairmanMarcello ConvitiChief Executive Officer

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil